Public access to protocols of contemporary cancer randomized clinical trials
- PMID: 34176506
- PMCID: PMC8237482
- DOI: 10.1186/s13063-021-05382-7
Public access to protocols of contemporary cancer randomized clinical trials
Abstract
Access to randomized clinical trial (RCT) protocols is necessary for the interpretation and reproducibility of the study results, but protocol availability has been lacking. We determined the prevalence of protocol availability for all published cancer RCTs in January 2020. We found that only 36.1% (48/133) of RCTs had an accessible protocol and only 11.3% of RCTs (15/133) had a publicly accessible protocol that was not behind a paywall. Only 18.0% (24/133) of RCTs were published in conjunction with the protocol on the journal website. In conclusion, few cancer RCTs have an accessible research protocol. Journals should require publication of RCT protocols along with manuscripts to improve research transparency.
Keywords: Access; Cancer; Clinical trials; Protocols.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
A meta-research study of randomized controlled trials found infrequent and delayed availability of protocols.J Clin Epidemiol. 2022 Sep;149:45-52. doi: 10.1016/j.jclinepi.2022.05.014. Epub 2022 May 30. J Clin Epidemiol. 2022. PMID: 35654268
-
Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting.J Clin Epidemiol. 2017 Nov;91:87-94. doi: 10.1016/j.jclinepi.2017.07.010. Epub 2017 Jul 27. J Clin Epidemiol. 2017. PMID: 28757260 Review.
-
Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.Oncotarget. 2017 Oct 3;8(57):97648-97656. doi: 10.18632/oncotarget.21459. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228640 Free PMC article.
-
Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysis.Clin Trials. 2020 Feb;17(1):99-105. doi: 10.1177/1740774519868310. Epub 2019 Aug 26. Clin Trials. 2020. PMID: 31450958
-
An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.J Clin Epidemiol. 2016 Jan;69:152-60. doi: 10.1016/j.jclinepi.2015.05.023. Epub 2015 Jun 4. J Clin Epidemiol. 2016. PMID: 26361993 Review.
Cited by
-
Evaluating the Generalizability and Reproducibility of Scientific Research.Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):1-4. doi: 10.1016/j.ijrobp.2022.02.002. Int J Radiat Oncol Biol Phys. 2022. PMID: 35427541 Free PMC article. No abstract available.
-
How do trial teams plan for retention during the design stage of the trial? A scoping review.Trials. 2023 Dec 4;24(1):784. doi: 10.1186/s13063-023-07775-2. Trials. 2023. PMID: 38049833 Free PMC article.
-
How do trial teams plan for retention during the design stage of the trial? A scoping review protocol.Trials. 2022 Nov 17;23(1):944. doi: 10.1186/s13063-022-06866-w. Trials. 2022. PMID: 36397085 Free PMC article.
-
Access to unpublished protocols and statistical analysis plans of randomised trials.Trials. 2022 Aug 17;23(1):674. doi: 10.1186/s13063-022-06641-x. Trials. 2022. PMID: 35978391 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical